Mission Statement

Aposcience AG aspires to improve the health of patients in need of regenerative medicine by commercially exploiting the therapeutic potential of secretomes of white blood cells (PBMCs) isolated from peripheral blood.

Latest News
Dec
12

Approval for clinical phase II study in DFU by Austrian health agency

[more]

Oct
10

US Patent Office issues Allowance for APOSEC Patent

[more]